Literature DB >> 6163715

Role of host cell metabolism in the pathogenesis of Mycoplasma pneumoniae infection.

S Upchurch, M G Gabridge.   

Abstract

Human lung fibroblasts develop a cytopathic effect (CPE) when infected with Mycoplasma pneumoniae. This study was designed to determine the relationship between host cell metabolism and the formation of the CPE. Human lung fibroblasts were grown in different serum concentrations, plated at different densities, and grown for different periods of time to alter the metabolic activity of the cells. Deoxyribonucleic acid, ribonucleic acid, and protein syntheses were measured by the ability of the cells to incorporate thymidine, uridine, and leucine, respectively. With each treatment, leucine incorporation remained constant. Thymidine and uridine incorporation was higher when the cells were in high serum, at low cell densities, or grown for 2 or 3 days. The appearance of an observable CPE, which was corroborated with a protein synthesis assay, correlated closely with thymidine and uridine incorporation. A more pronounced CPE was seen when thymidine and uridine incorporation was high. In addition, it was found that the first 2 h after infection by M. pneumoniae were the critical hours in determining whether a CPE would develop. This was accomplished by altering the serum concentration of the culture medium at different times postinfection and thereby altering the metabolism of the fibroblasts. These results demonstrate the importance of the metabolic state of the host cells in studying mycoplasma infections and establish a correlation between the nucleic acid metabolism of the cells and the production of a CPE.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6163715      PMCID: PMC351767          DOI: 10.1128/iai.31.1.174-181.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Oxygen consumption by trachea organ cultures infected with Mycoplasma pneumoniae.

Authors:  M G Gabridge
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

2.  Nucleotide and pentose synthesis after serum-stimulation of resting 3T6 fibroblasts.

Authors:  M L Smith; J M Buchanan
Journal:  J Cell Physiol       Date:  1979-11       Impact factor: 6.384

3.  Cultivation of mycoplasmas in a modified tissue culture medium.

Authors:  M G Gabridge; S E Singer; R A Esposito
Journal:  Appl Environ Microbiol       Date:  1976-06       Impact factor: 4.792

4.  Regulation of protein synthesis during density-dependent growth inhibition of BHK21-13 cells.

Authors:  N L Baenziger; C H Jacobi; R E Thach
Journal:  J Biol Chem       Date:  1974-06-10       Impact factor: 5.157

5.  Characteristics of a human diploid cell designated MRC-5.

Authors:  J P Jacobs; C M Jones; J P Baille
Journal:  Nature       Date:  1970-07-11       Impact factor: 49.962

6.  Quantitative aspects of Mycoplasma pneumoniae-cell relationships in cultures of lung diploid fibroblasts.

Authors:  N M Larin; N V Saxby; D Buggey
Journal:  J Hyg (Lond)       Date:  1969-09

7.  Differences in the attachment of Mycoplasma pneumoniae cells and membranes to tracheal epithelium.

Authors:  M G Gabridge; Y D Barden-Stahl; R B Polisky; J A Engelhardt
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

8.  CYTOPATHIC EFFECT OF THE ATYPICAL PNEUMONIA ORGANISM IN CULTURES OF HUMAN TISSUE.

Authors:  M D Eaton; A E Farnham; J D Levinthal; A R Scala
Journal:  J Bacteriol       Date:  1962-12       Impact factor: 3.490

9.  Interaction of Mycoplasma pneumoniae with human lung fibroblasts: characterization of the in vitro model.

Authors:  M G Gabridge; D Taylor-Robinson; H A Davies; R R Dourmashkin
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

10.  Intracellular levels of adenosine triphosphate in hamster trachea organ cultures exposed to Mycoplasma pneumoniae cells or membranes.

Authors:  M G Gabridge; R B Polisky
Journal:  In Vitro       Date:  1977-08
View more
  13 in total

1.  Enzymatic activities in cell fractions of mycoplasmalike organisms purified from aster yellows-infected plants.

Authors:  Y K Arora; R C Sinha
Journal:  J Bacteriol       Date:  1985-11       Impact factor: 3.490

2.  Parasitism of hamster trachea epithelial cells by Mycoplasma pneumoniae.

Authors:  Y Y Chen; D C Krause
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

3.  Hemadsorption and virulence are separable properties of Mycoplasma pneumoniae.

Authors:  D K Leith; E J Hansen; R M Wilson; D C Krause; J B Baseman
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

4.  De novo purine synthesis, purine salvage, and DNA synthesis in normal and Lesch-Nyhan fibroblasts infected with Mycoplasma pneumoniae.

Authors:  S Upchurch; M G Gabridge
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

5.  Identification of Mycoplasma pneumoniae proteins associated with hemadsorption and virulence.

Authors:  D C Krause; D K Leith; R M Wilson; J B Baseman
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

6.  Properties of the nucleases of mollicutes.

Authors:  J D Pollack; P J Hoffmann
Journal:  J Bacteriol       Date:  1982-10       Impact factor: 3.490

7.  Antigenic mimicry of mammalian intermediate filaments by mycoplasmas.

Authors:  K S Wise; R K Watson
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

8.  Characterization of hemadsorption-negative mutants of Mycoplasma pneumoniae.

Authors:  E J Hansen; R M Wilson; W A Clyde; J B Baseman
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

9.  Alterations in nucleotide content of human lung fibroblasts infected with Mycoplasma pneumoniae.

Authors:  S Upchurch; M G Gabridge
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

10.  Differential cytopathogenicity accompanying Mycoplasma pneumoniae infection of human lung fibroblasts maintained in newborn bovine serum or fetal bovine serum.

Authors:  S Upchurch; M G Gabridge
Journal:  In Vitro       Date:  1983-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.